Document:

Exhibit 10.1

                         EXCLUSIVE TECHNOLOGY LICENSE
                                      AND
                      RIGHT TO PURCHASE PATENTS AGREEMENT

      THIS  AGREEMENT, effective May 25, 2004, is entered into by Paul V. Vose,
as an individual,  with  offices located at 513 N. Truesdale Rd., Medical Lake,
Washington, 99022 (herein  called  LICENSOR)  and Integrated Micrometallurgical
Systems, Inc., a corporation organized pursuant  to  the  laws  of the state of
Nevada,  with its principal place of business at 7925 North Espe Rd.,  Spokane,
WA  99217 (herein called LICENSEE).

                                   ARTICLE I
                            BACKGROUND OF AGREEMENT

      LICENSOR  represents that he it is the owner of the right to file PATENTS
and  IMPROVEMENTS,   PROPRIETARY  INFORMATION,  TRADE  SECRETS,  TECHNICAL  and
SCIENTIFIC information  and KNOW-HOW, all  pertaining to several designs of the
Chemically enhanced micro  diffusion  techniques  for  advanced  lubricity  and
corrosion protection (herein called TECHNOLOGY).  LICENSOR is prepared to grant
an  exclusive  license  to LICENSEE and assign all right, title and interest in
all domestic and foreign  patents  granted at a future date, subject to certain
terms and conditions.

      1.01        LICENSEE wishes to  acquire  an exclusive license pursuant to
the  issuance  of  future  domestic  and  foreign  PATENTS   and  IMPROVEMENTS,
PROPRIETARY  INFORMATION, TRADE SECRETS, TECHNICAL and SCIENTIFIC  information,
KNOW-HOW and registered  TRADEMARKS  of  LICENSOR for purposes of making, using
and selling the TECHNOLOGY on a worldwide basis.

      1.02        LICENSEE wishes to acquire  all  right, title and interest in
all domestic and foreign patents filed as of the date  of  this  agreement that
related to the TECHNOLOGY and any domestic or foreign patents filed and granted
in  the  future  by  the  LICENSOR,  including all improvements on domestic  or
foreign  patents  filed  or to be filed in  the  future,  pursuant  to  certain
considerations in the form  of a Product Royalty to be paid to the LICENSOR, by
the LICENSEE or SUBLICENSES.

                                  ARTICLE II
                                  DEFINITIONS

      As used herein, the following  terms  shall  have  the meanings set forth
below:

      2.00        CONFIDENTIAL   INFORMATION  is  that  information   that   is
transmitted by LICENSOR and received by LICENSEE that is considered by LICENSOR
to be CONFIDENTIAL and PROPRIETARY INFORMATION.

      2.01        EFFECTIVE DATE shall be May 25, 2004.

      2.02        GROSS PRODUCTION  means  the  number of units of commercially
saleable products produced by utilization of the  LICENSED TECHNOLOGY, with the
LICENSED PRODUCT and sold to customers of LICENSEE  or  sold by SUB-LICENSEE(S)
of LICENSEE.

      2.03        IMPROVEMENTS  means any modification of  a  method,  process,
composition of matter, process or  product described in a PATENT, TRADE SECRET,
TECHNICAL  and SCIENTIFIC information,  KNOW-HOW,  or  in  any  PROPRIETARY  or
CONFIDENTIAL   INFORMATION  of  LICENSOR,  provided  such  a  modification,  if
unlicensed, would  infringe  one  or  more  claims  of an issued patent, PATENT
APPLICATION, TRADE SECRET, TECHNICAL and SCIENTIFIC information,  KNOW-HOW,  or
in  any  other  PROPRIETARY  or CONFIDENTIAL INFORMATION.  IMPROVEMENTS further
mean any modifications or changes  in  the composition of matter, change in the
design or use of the LICENSED PRODUCT or LICENSED TECHNOLOGY by LICENSEE.

      2.04        KNOW-HOW means that special  knowledge, skill and experience,
as  applied to the LICENSED PRODUCT and the LICENSED  PROCESS  and  TECHNOLOGY,
that  is  possessed  by  the  LICENSOR  that  is  PROPRIETARY  or  CONFIDENTIAL
INFORMATION.

      2.05        LICENSED  FIELD  means,  and  is limited to, the practice  of
PATENT(S) and IMPROVEMENTS, PATENTS that may issue  in  the future, PROPRIETARY
INFORMATION, TRADE SECRETS, TECHNICAL and SCIENTIFIC information  and  KNOW-HOW
for  purposes  of using the LICENSED PRODUCT and the LICENSED TECHNOLOGY on  an
exclusive worldwide basis.

      2.06        LICENSED PRODUCTS or DESIGNS means any and all products which
fall within the LICENSED FIELD and which are covered by, marked or are produced
using a process  or  method covered by a claim of a PATENT(S) and IMPROVEMENTS,
PROPRIETARY INFORMATION,  TRADE  SECRETS,  TECHNICAL and SCIENTIFIC information
and  KNOW-HOW  of  LICENSOR  for purposes of commercially  using  the  LICENSED
TECHNOLOGY.

      2.07        LICENSED PROCESS  AND TECHNOLOGY means any and all process or
proprietary technology, engineering and  design  features  or  components which
fall  within  the  LICENSED FIELD which were developed by the LICENSOR  or  his
affiliates and which  are covered by, marked or are produced using a process or
method  covered  by  a claim  of  a  PATENT(S)  and  IMPROVEMENTS,  PROPRIETARY
INFORMATION, TRADE SECRETS,  TECHNICAL  and SCIENTIFIC information and KNOW-HOW
of LICENSOR for purposes of commercially utilizing the LICENSED PRODUCT.

      2.08        LICENSED TERRITORY shall mean all countries of the world.

      2.09        LICENSEE means INTEGRATED MICROMETALLURGICAL SYSTEMS, INC., a
corporation domiciled in the state of Nevada.

      2.10        LICENSOR means Paul V. Vose as an individual.

      2.11        NET SELLING PRICE means the gross amount received by LICENSEE
or a SUBLICENSE relating to any and all products  (consumable  or equipment) or
services sold by LICENSEE or SUBLICENSE resulting from the use of  the LICENSED
PRODUCT  AND  LICENSED  TECHNOLOGY,  less the cost of freight required for  the
transport of the product sold to a third party buyer.

      2.12        PATENT(S), PROVISIONAL  PATENT(S)  or  PATENT  APPLICATION(S)
means any PATENT(S) granted or PATENT APPLICATION(S) made by LICENSOR  pursuant
thereto,  and  all  divisions,  continuations, continuations in part, reissues,
substitutes, and extensions thereof.

      2.13        PRIVATE LABEL means the exclusive labeling, trade name and/or
trademark for the LICENSED PRODUCT  or LICENSED TECHNOLOGY used by the LICENSEE
or a SUBLICENSEE in the LICENSED TERRITORY.

      2.14        PROPRIETARY INFORMATION  means  all  information possessed by
the LICENSOR that is CONFIDENTIAL in nature and that the LICENSOR has exclusive
rights  in  and  to.   It  includes  TRADE  SECRETS, TECHNICAL  and  SCIENTIFIC
information, and KNOW-HOW as related to the LICENSED  PRODUCTS and the LICENSED
TECHNOLOGY.

      2.15        PRODUCT ROYALTY means a royalty payment  made by the LICENSEE
or SUBLICENSEE(S) to the LICENSOR on the products actually sold  by LICENSEE or
SUBLICENSEE(S)  and  paid  for  by customers of the LICENSEE OR SUBLICENSEE(S).
The ROYALTY shall be THREE PERCENT  (3%)  of  the  NET  SELLING  PRICE,  of all
products,  equipment,  consumables  and  services  sold by LICENSEE directly to
third  parties  or  SUBLICENSEE(S).  In the event the LICENSEE  enters  into  a
SUBLICENSE AGREEMENT,  the  LICENSOR  shall  receive 30% of all PRODUCT ROYALTY
income paid to the LICENSEE by any SUBLICENSEE(S),  less  ROYALTIES  previously
paid  on from previous sales product or PRODUCT ROYALTY, if any, actually  paid
by LICENSEE to LICENSOR.

      2.16        SUBLICENSE  means  an  Exclusive  License  granted to a third
party  by the LICENSEE of the LICENSED PRODUCT or LICENSED TECHNOLOGY,  in  the
LICENSED FIELD and IN A PORTION of the LICENSED TERRITORY.

      2.17        TECHNICAL  and  SCIENTIFIC  information means all PROPRIETARY
INFORMATION, TRADE SECRETS, KNOW-HOW and all information contained in PATENT(S)
that may issue or PATENT APPLICATION(S) and IMPROVEMENTS  that is the exclusive
property  of  LICENSOR developed or acquired as of the date of  this  agreement
which would be useful in the making, using and selling of the LICENSED PRODUCTS
in the LICENSED TERRITORY.

      2.18        TRADE  SECRET  means any CONFIDENTIAL INFORMATION that is the
personal property of LICENSOR and in which he has an exclusive right.

                                  ARTICLE III
                                 LICENSE GRANT

      3.00        LICENSOR hereby  grants  to  LICENSEE,  to  the extent of the
LICENSED  FIELD, a license under any PATENT(S) or PATENT APPLICATION(S)  to  be
filed  and  IMPROVEMENTS,  PROPRIETARY  INFORMATION  including  TRADE  SECRETS,
TECHNICAL and SCIENTIFIC information, and KNOW-HOW for the purpose of using the
LICENSED  PRODUCTS  and  the  LICENSED  PROCESS  and  TECHNOLOGY,  that  is  an
integrated  operating  system  and related technology collectively and commonly
referred to as the Nanomet Technology,  which  in general relates to Chemically
enhanced  micro  diffusion  techniques  for advanced  lubricity  and  corrosion
protection, in the LICENSED TERRITORY.

      No LICENSE under the PATENT(S) or PATENT  APPLICATION(S)  to be filed and
IMPROVEMENTS,  PROPRIETARY  INFORMATION including TRADE SECRETS, TECHNICAL  and
SCIENTIFIC information, KNOW-HOW  is granted, and no license should be implied,
with respect to activities of LICENSOR  outside the LICENSED FIELD and LICENSED
TERRITORY.
            (A)   The  Parties agree that  any  IMPROVEMENTS,  design  changes,
modifications  or  developments   of  the  LICENSED  PRODUCT  or  the  LICENSED
TECHNOLOGY, made by LICENSOR shall  be  available  to  LICENSEE in the LICENSED
TERRITORY at no additional cost or increased ROYALTY.  In  the  event  LICENSOR
makes application for any new patent, LICENSEE shall have the right to use  and
purchase  for  $1.00  and  other  good  and  valuable  consideration, any newly
developed product, process or technology under this Agreement.
            (B)   The  Parties  further  agree  that  any IMPROVEMENTS,  design
changes,  modifications  or developments of the LICENSED  PRODUCT  or  LICENSED
TECHNOLOGY made by LICENSEE,  which may be patented, may be made or used in the
LICENSED TERRITORY by the LICENSEE.  LICENSEE shall promptly inform LICENSOR of
any such IMPROVEMENTS or of the  filing of any patent applications by LICENSEE.
LICENSEE shall grant to LICENSOR,  for  no  consideration,  and on a ROYAL free
basis,  an  exclusive  license on a worldwide basis.  Any IMPROVEMENTS,  design
changes, modifications or  developments  of  the  LICENSED  PRODUCT or LICENSED
TECHNOLOGY  by  LICENSEE  are  construed  to  be  a part of this Agreement  and
LICENSEE  shall  be  bound  to  all  terms  and conditions  contained  in  this
Agreement.

      3.01        LICENSOR further grants to  LICENSEE,  to  the  extent of the
LICENSED  FIELD  and  LICENSED  TERRITORY,  a  license  to  use  any registered
TRADEMARK, owned, acquired, developed or filed for by the LICENSOR, relating to
the LICENSED PRODUCT or LICENSED PROCESS and TECHNOLOGY.

      3.02        The  PRODUCT  LICENSE granted pursuant to Sections  3.00  and
3.01  shall  be  exclusive,  with the  right  to  grant  EXCLUSIVE  SUBLICENSES
thereafter for the term of this  Agreement  as  defined  in  Article  VI.  Such
approval shall not be unreasonably withheld.  Any

EXCLUSIVE SUBLICENSE agreement of LICENSEE shall be bound by all terms  of this
Agreement, unless expressly excluded in writing, by LICENSOR.

                                  ARTICLE IV
               LICENSE FEES, ROYALTIES AND PAYMENTS FOR PATENTS

      4.00        LICENSEE  shall,  on the EFFECTIVE DATE, due on May 25, 2007,
as a one time only LICENSEE FEE, pay  to LICENSOR, Twenty Five Thousand Dollars
($25,000),  which shall be non-refundable  and  credited  against  the  ROYALTY
called for under  Section  4.01.   The  LICENSE  FEE  of  Twenty  Five Thousand
($25,000), to be paid to the LICENSOR by the LICENSEE will at the option of the
LICENSOR  be  made  up of One Hundred Twenty Five Thousand (125,000) shares  of
restricted common stock of Integrated Micrometallurgical Systems, Inc valued at
$.20 per share or a cash  payment of Twenty Five Thousand ($25,000) Dollars and
a five (5) year stock option  to purchase an additional One Hundred Twenty Five
(1,250,000) shares of restricted common stock at $.20 per share.

      4.01        LICENSEE shall  pay  to  LICENSOR  a royalty on the products,
equipment, consumables and services sold by LICENSEE and  paid for by customers
of the LICENSEE.  The PRODUCT ROYALTY shall be THREE PERCENT  (3%)  of  the NET
SELLING PRICE of LICENSED PRODUCT, of all products, equipment, consumables  and
services  sold  by  LICENSEE  directly  to  third  parties or SUBLICENSEE, less
ROYALTIES paid on product returned from previous sales  of  product, equipment,
consumables  and  services  sold,  if  any,  actually paid by LICENSEE  or  the
SUBLICENSEE.  In the event the LICENSEE enters into a SUBLICENSE AGREEMENT, the
LICENSOR shall receive 30% of all PRODUCT ROYALTY  income  paid to the LICENSEE
by any SUBLICENSEE(S).  The ROYALTY due from the LICENSEE to  the LICENSOR will
remain in perpetuity and continued to be paid beyond the life of any PATENTS or
termination  of  this  agreement  or any SUBLICENSE agreements.   Payments  and
accounting are to be made quarterly,within 30 days of the quarter just ending.

                                   ARTICLE V
                RIGHT TO PURCHASE PATENTS AT THE TIME OF GRANT

      5.00        In the event the  LICENSOR  is  granted  domestic  or foreign
patents issued in the future, the LICENSOR hereby agree that within Sixty  (60)
days  they  will  execute  any and all documents necessary to legally assign or
transfer all right, title and  interest  of the PATENTS to the LICENSEE for One
Dollar ($1.00) and other good and valuable  consideration.  It being understood
that so long as this AGREEMENT remains in good standing, the LICENSEE agrees to
assume financial responsibility to pay directly  or  reimburse the LICENSOR for
all costs related preparing and prosecution patent applications  on  behalf  of
the LICENSOR, including but not limited to legal fees, filing fees, maintenance
fees and translation costs.

                                  ARTICLE VI
                                  SUBLICENSES

      6.0   Any  SUBLICENSE  in the LICENSED FIELD and LICENSED TERRITORY shall
be the responsibility of LICENSEE  so long as this Agreement remains exclusive.
It  is  the  intent  of the parties that  SUBLICENSES  shall  be  available  to
qualified third parties on fair and reasonable terms.  A SUBLICENSE shall be an
exclusive  license  that  is  transferable  only  from  LICENSEE  with  written
authorization of LICENSOR.   Written  authorization  shall  not be unreasonably
withheld.  LICENSEE shall supply LICENSOR with a copy of each  such  SUBLICENSE
agreement thirty (30) days prior to the proposed date of the execution  of  the
SUBLICENSE agreement.  LICENSOR shall within a fifteen day (15) period, provide
written  authorization  or  state in writing the issues it believes are legally
valid justifications for not providing authorization to the LICENSEE to execute
the SUBLICENSE agreement.

      6.01        LICENSEE shall  pay  to  LICENSOR  fifty percent (50%) of any
fees  or  consideration received by the LICENEE pursuant  the  execution  of  a
SUBLICENSE  agreement or other considerations resulting from the execution of a
SUBLICENSE  agreement.   SUBLICENSE  fees  and  other  considerations  paid  to
LICENSOR shall  be  applied  to  the  ROYALTY due LICENSOR under Sections 4.01.
LICENSOR will be entitled to Thirty Percent (30%) of all PRODUCT ROYALTY income
generated by LICENEE as a result of any SUBLICENSE(S) agreement(s).

      6.02        PRODUCT ROYALTY for a  SUBLICENSE shall be not less than that
set forth for in Sections 4.01.

      6.03        LICENSEE  shall  pay  to LICENSOR  thirty  percent  (30%)  of
PRODUCT  ROYALTY  income  or  the  equivalent,  received  by  LICENSEE  from  a
SUBLICENSE or other such similar agreement.   Payment  of  LICENSOR'S  share of
SUBLICENSE income shall be made to LICENSOR quarterly basis as provided  for in
ARTICLE  10.00.  SUBLICENSE fees paid to LICENSOR shall be applied to the total
amount due  LICENSOR  pursuant to ARTICLE 12.00 and to the ROYALTY due LICENSOR
under Section 4.01.

      6.04        If this Agreement becomes nonexclusive or if it is terminated
for any reason, LICENSEE  shall  immediately assign all of its right, title and
interest to all SUBLICENSES to LICENSOR,  including  the  right  to receive all
income  from  the  SUBLICENSE.   LICENSEE  shall,  prior  to execution of  each
SUBLICENSE,  make  the SUBLICENSEE aware of this contingency.   All  terms  and
conditions of any SUBLICENSE  agreement  will  be consistent with the terms and
conditions of this LICENSE AGREEMENT.

      6.05        Any SUBLICENSE Agreement of LICENSEE  shall  incorporate  and
contain the terms of this Agreement.  Any modifications, additions or deletions
of  this  Agreement,  as  incorporated  into  a  SUBLICENSE  Agreement, must be
approved by LICENSOR in writing.

      6.06        SUBLICENSEE must inform LICENSOR of any IMPROVEMENTS  of  the
LICENSED  PRODUCT  by  SUBLICENSEE.   SUBLICENSEE must comply with the terms of
Section 3.00(b) of this Agreement.

                                  ARTICLE VII
                                  EXPORTATION

      7.00        LICENSEE shall be limited  to the use of the LICENSED PRODUCT
or  LICENSED  PROCESS  and TECHNOLOGY in the LICENSED  FIELD  to  the  LICENSED
TERRITORY.  LICENSEE shall  not export the LICENSED PRODUCT or LICENSED PROCESS
and TECHNOLOGY to countries or territories that would be deemed to be high risk
with  regard to utilizing the  technology  without  legal  authorization.   Any
country  to  which  the  LICENSEE  proposes  to grant SUBLICENSES to, must have
without written authorization and consent from the LICENSOR.

      7.01        SUBLICENSE agreements shall  be  limited  to  the  use of the
LICENSED  PRODUCT  or LICENSED TECHNOLOGY in the LICENSED FIELD to the LICENSED
TERRITORY.  SUBLICENSEE(S)  shall  not  export  LICENSED  PRODUCT  or  LICENSED
TECHNOLOGY  to  any  customer  in  any  country  or  territory  without written
notification to and receipt of written authorization and consent from LICENSOR.

      7.02        In  the  event the LICENSEE grants and executes a  SUBLICENSE
agreement that is approved by  LICENSOR,  it is understood that all proprietary
components of the LICENSED PRODUCT shall be  purchase  exclusively  through the
LICENSEE or the LICENSOR.

                                 ARTICLE VIII
                                CONFIDENTIALITY

      8.00  LICENSEE, LICENSEE'S employees and SUBLICENSEES shall not disclose,
by  any  method  of  communication, any PROPRIETARY INFORMATION, TRADE SECRETS,
TECHNICAL  and  SCIENTIFIC   information,   KNOW-HOW   or   other  CONFIDENTIAL
INFORMATION expressly or implied disclosed by LICENSOR to LICENSEE  without the
expressed written permission of LICENSOR.

      8.01  LICENSEE  shall sign a separate Confidentiality Agreement  relative
to  any  PROPRIETARY  INFORMATION,  TRADE  SECRETS,  TECHNICAL  and  SCIENTIFIC
information, KNOW-HOW or  other  CONFIDENTIAL INFORMATION disclosed by LICENSOR
to LICENSEE.

      8.02        Any SUBLICENSE Agreement  of  LICENSEE  shall incorporate and
contain  the terms of Article VI and VII of this Agreement and  any  SUBLICENSE
shall sign  a  separate  Confidentiality  Agreement  with  LICENSEE relative to
PROPRIETARY  and  CONFIDENTIAL  INFORMATION  received  as  the result  of  this
Agreement.

                                  ARTICLE IX
                                PRIVATE LABELS

      9.00        All LICENSED PRODUCT used pursuant to this LICENSE AGREEMENT,
may  be  used under any TRADEMARK(S) developed or owned by the  LICENSOR  or  a
TRADEMARK developed and owned by the LICENSEE.  In the event that any TRADEMARK
utilized by  the LICENSEE, is in conflict with another company operating within
any country in the TERRITORY, any other such PRIVATE LABEL selected by LICENSEE
or SUBLICENSEE may be used.

      9.01  The  PRIVATE  LABEL  of  the LICENSED PRODUCT shall comply with the
appropriate regulations of all governmental  agencies of the country within the
TERRITORY.

      9.02  As long as this exclusive LICENSEE AGREEMENT or any modification or
extension thereof remains in force and effect,  LICENSEE  shall  own  each such
PRIVATE  LABEL  or  trademark  to  be  used exclusively by LICENSEE on LICENSED
PRODUCT.
                                   ARTICLE X
                                   PAYMENTS

      10.00       Not later than the last  day of each January, April, July and
October, LICENSEE and all SUBLICENEE(S) shall  furnish  to  LICENSOR  a written
statement in such detail as LICENSOR may reasonably require of all amounts  due
pursuant  to Sections 4.01 for the quarterly periods ended the last days of the
preceding March,  June,  September and December, respectively, and shall pay to
LICENSOR, all amounts due to LICENSOR.

      10.01       Payments  provided for in this Agreement, when overdue, shall
bear interest at a rate per annum  equal to three percent (3%) in excess of the
"PRIME RATE" published by the U.S. Edition  of "The Wall Street Journal" at the
time such payment is due, and for the time period  until payment is received by
LICENSOR.

      10.02       If this Agreement is for any reason  terminated before all of
the  payments  herein provided for have been made, LICENSEE  shall  immediately
submit a terminal report, and pay to LICENSOR any remaining unpaid balance even
though the due date as above provided has not been reached.

                                  ARTICLE XI
                 REPRESENTATIONS AND DISCLAIMER OF WARRANTIES

      11.00       NOTHING   IN   THIS   AGREEMENT  SHALL  BE  DEEMED  TO  BE  A
REPRESENTATION OR WARRANTY BY LICENSOR OF  THE VALIDITY OF ANY PATENTS, PATENTS
THAT  MAY ISSUE, PATENT APPLICATIONS AND IMPROVEMENTS,  PROPRIETARY  KNOWLEDGE,
TRADE SECRETS,  TECHNICAL  AND  SCIENTIFIC INFORMATION, KNOW-HOW AND REGISTERED
TRADEMARKS LICENSOR SHALL HAVE NO LIABILITY WHATSOEVER TO LICENSEE OR ANY OTHER
PERSON FOR, OR ON ACCOUNT OF ANY  INJURY, LOSS OR DAMAGE OF ANY KIND OR NATURE,
SUSTAINED  BY,  OR  ANY DAMAGE ASSESSED  OR  ASSERTED  AGAINST,  OR  ANY  OTHER
LIABILITY INCURRED BY OR IMPOSED UPON LICENSEE OR ANY OTHER PERSON, ARISING OUT
OF OR IN CONNECTION WITH, OR RESULTING FROM:

            (A)   THE  PRODUCTION,  USE OR SALE OF ANY APPARATUS OR PRODUCT, OR
THE  PRACTICE  OF  ANY  PATENTS  THAT  MAY   ISSUE,   PATENT   APPLICATIONS  OR
IMPROVEMENTS; OR

            (B)   ANY ADVERTISING OR OTHER PROMOTIONAL ACTIVITIES  WITH RESPECT
TO ANY OF THE FOREGOING.

      LICENSEE  SHALL  HOLD  LICENSOR,  AND  ITS  PARTNERS, AGENTS OR EMPLOYEES
HARMLESS IN THE EVENT LICENSOR, OR ITS OFFICERS, AGENTS  OR  EMPLOYEES, IS HELD
LIABLE.

      11.01       LICENSOR shall have the right to file, prosecute and maintain
PATENT  APPLICATIONS  and  IMPROVEMENTS that are the property of  LICENSOR  and
shall have the right to determine  whether  or  not, and where to file a patent
application or to abandon the prosecution of any patent or patent application.

                                  ARTICLE XII
                                  TERMINATION

      12.00       This Agreement shall terminate:

            (A)   upon the expiration of the last  to  expire of any PATENT(S),
PATENT(S) that may issue; or

            (B)   upon  the  abandonment  of the last to be  abandoned  of  any
PATENT APPLICATIONS and IMPROVEMENTS, included herein; and

            (C)   upon termination of this  Agreement the PRODUCT ROYALTY shall
continue in perpetuity.

            (D)   IF THE ONE TIME ONLY LICENSE FEE TOTALING $25,000 IS NOT PAID
ON OR BEFORE MAY 24, 2007.

      12.01       LICENSEE may terminate this  Agreement at any time upon sixty
(60) days written notice in advance to LICENSOR.

      12.02       If either party shall be:
            (A)   in default of any obligation hereunder; or
            (B)   shall be adjudged bankrupt; or

            (C)   shall become insolvent; or
            (D)   shall make an assignment for the benefit of creditors; or
            (E)   shall be placed in the hands of  a  receiver  or a trustee in
bankruptcy, the other party may terminate this Agreement by giving  sixty  (60)
days  notice  by  Registered  Mail to the other party, specifying the basis for
termination.  If within sixty (60)  days  after the receipt of such notice, the
party receiving notice shall remedy the condition  that  formed  the  basis for
termination, such notice shall cease to be operative, and this Agreement  shall
continue in full force.

      12.03       The word "termination" and cognate words, such as "term"  and
"terminate",  used in Article XII and elsewhere in this agreement, are to read,
except where the  contrary  is  specifically  indicated, as omitting from their
effect,  the  following  rights  and  obligations, all  of  which  survive  any
termination to the degree necessary to  permit  their  complete  fulfillment or
discharge:
            (A)   LICENSEE'S   obligation  to  supply  a  terminal  report   as
specified in paragraph 10.02 of this Agreement;
            (B)   LICENSOR'S  right  to  receive  or  recover,  and  LICENSEE'S
obligation to pay royalties (including  minimum ROYALTIES) accrued or accruable
for payment at the time of any termination;
            (C)   LICENSEE'S obligation to maintain records under Section under
15.00 of this Agreement;
            (D)   licenses, releases and  agreements of nonassertion running in
favor of customers or transferees of LICENSEE  in  respect  to products sold or
transferred by LICENSEE prior to any termination and on which  ROYALTIES  shall
have been paid as provided in paragraph 4.01 of this Agreement;
            (E)   any  cause  of  action  or  claim  of  LICENSOR accrued or to
accrue, because of any breach or default by LICENSEE; and

                                 ARTICLE XIII
                                  ARBITRATION

      13.00       Any controversy or dispute arising out of  or  in  connection
with this Agreement, its interpretation, performance, or termination, which the
parties are unable to resolve within a reasonable time after written notice  by
one  party to the other of the existence of such controversy or dispute, may be
submitted  to  arbitration by either party and if so submitted by either party,
shall be finally  settled by arbitration conducted in accordance with the rules
of conciliation and  arbitration  of  the  Chamber of Commerce in effect on the
date hereof.  Any such arbitration shall take  place  in the City of Las Vegas,
Nevada.  Such arbitration shall be conducted in the English  language  and  the
arbitrators shall apply the laws of the Country of the United States.

      3.01        The institution of any arbitration proceeding hereunder shall
not  relieve  LICENSEE  of  its  obligation  to make payments accrued hereunder
pursuant to Sections 4.00 hereof to LICENSOR during  the  continuance  of  such
proceeding.   The  decision  by the arbitrators shall be binding and conclusive
upon the parties, their successors, and assigns and they shall comply with such
decision  in  good  faith,  and  each   party  hereby  submits  itself  to  the
jurisdiction of the courts of the place where the arbitration is held, but only
for  the  entry  judgment  with  respect to the  decision  of  the  arbitrators
hereunder.  Notwithstanding the foregoing,  judgment  upon award may be entered
in  any  court  where  the  arbitration  takes  place,  or  any   court  having
jurisdiction.

      13.02       Any  SUBLICENSE  agreement of LICENSEE shall incorporate  and
contain the terms of Article 13.00 of this Agreement.

                                  ARTICLE XIV
                                  LITIGATION

      14.00       Each party shall notify  the  other  party  in writing of any
suspected infringement(s) of any PATENT(S) or PATENT(S) that may  issue, PATENT
APPLICATIONS   and   IMPROVEMENTS,   PROPRIETARY  INFORMATION,  TRADE  SECRETS,
TECHNICAL and SCIENTIFIC information, KNOW-HOW and registered TRADEMARKS in the
LICENSED TERRITORY, and shall inform the  other  party  of any evidence of such
infringement(s).

      14.01       LICENSOR  shall have the first right to  institute  suit  for
infringement(s) in the LICENSED  FIELD  and  the  LICENSED TERRITORY.  LICENSEE
agrees to join as a party plaintiff in any such lawsuit  initiated by LICENSOR,
if  requested by LICENSOR, with all costs, attorney fees, and  expenses  to  be
paid   by   LICENSOR.   However,  if  LICENSEE  does  not  institute  suit  for
infringement(s)  within  ninety  (90)  days  of  receipt of written notice from
LICENSEE of LICENSOR'S desire to bring suit for infringement  in  its  own name
and  on  its  own behalf, then LICENSEE may, at its own expense, bring suit  or
take any other appropriate action.

      14.02       If   this   Agreement   is   non-exclusive  at  the  time  of
infringement(s),  the  sole right to institute suit  for  infringement  and  to
recover damages shall rest with LICENSOR.

      14.03       LICENSEE  shall  be  entitled  to  any  recovery  of  damages
resulting  from  a lawsuit brought by it pursuant to paragraph 14.01.  LICENSOR
shall be entitled  to recovery of damages resulting from any lawsuit brought by
LICENSOR to enforce any patent that my issue pursuant to paragraph 14.01.
      14.04       Either  party  may settle with an infringer without the prior
approval of the other party if such  settlement  would not affect the rights of
the  other  party  under  any  patent that may issue, PATENT  APPLICATIONS  and
IMPROVEMENTS, PROPRIETARY INFORMATION,  TRADE SECRETS, TECHNICAL and SCIENTIFIC
information, KNOW-HOW and registered TRADEMARKS.

      14.05       Any SUBLICENSE agreement  of  LICENSEE  shall incorporate and
contain the terms of Article XIV of this Agreement.

                                  ARTICLE XV
                                    RECORDS

      15.00       LICENSEE  shall  keep  accurate  records  of  all  operations
affecting payments hereunder, and shall permit LICENSOR or its duly  authorized
agent  to inspect all such records and to make copies of or extracts from  such
records during regular business hours throughout the term of this Agreement and
for a reasonable period of not less than three (3) years thereafter.

      15.01       Any  SUBLICENSE  agreement  of LICENSEE shall incorporate and
contain the terms of Article XV of this Agreement.

                                  ARTICLE XVI
                            PATENT MAINTENANCE FEES

      16.00       Pursuant to PATENT(S) and in  the event that patents issue on
PATENT  APPLICATIONS  and IMPROVEMENTS, described in  Section  2.11,  or  other
patents  subsequently issue  related  to  the  LICENSED  PRODUCT  and  LICENSED
TECHNOLOGY,  maintenance  fees  shall  be  paid  by  LICENSOR and reimbursed by
LICENSEE  and  all  documentation  of  payment shall be provided  to  LICENSEE.
LICENSOR, upon request by LICENSEE, shall  provide  LICENSEE  with  records and
schedule of maintenance fee due dates.

                                 ARTICLE XVII
                               NON-ASSIGNABILITY

      17.00       The  parties  agree  that  this  agreement  imposes  personal
obligations  on  LICENSEE.   LICENSEE  shall  not  assign any rights under this
Agreement not transferable by terms without the written  consent  of  LICENSOR.
LICENSOR may assign his rights hereunder.

                                 ARTICLE XVIII
                                 SEVERABILITY

      18.00       The parties agree that if any part, term or provision of this
Agreement shall be found illegal or in conflict with any valid controlling law,
the validity of the remaining provisions shall not be affected thereby.

      18.01       In  the event the legality of any provision of this agreement
is brought into question  because  of  a  decision  by  a  court  of  competent
jurisdiction, LICENSOR, by written notice to LICENSEE, may revise the provision
in question or may delete it entirely so as to comply with the decision of said

court.

                                  ARTICLE XIX
                          NON-USE OF LICENSOR'S NAME

      19.00       In  publicizing  anything used under this Agreement, LICENSEE
shall  not use the name of LICENSOR or  otherwise  refer  to  any  organization
related to LICENSOR, except with the written approval of LICENSOR.  LICENSEE is
authorized to make public the name of the LICENSOR and describe the contractual
relationship  between  the LICENSOR and LICENSEE if LICENSEE becomes a publicly
traded company and the disclosures  are  a  requirement  and  pursuant  to  the
requirements of the Securities Act of 1933 or 1934.

                                  ARTICLE XX
                        WAIVER, INTEGRATION, ALTERATION

      20.00       The  waiver  of  a breach hereunder may be affected only by a
writing signed by the waiving party  and  shall  not constitute a waiver of any
other breach.

      20.01       This  Agreement represents the entire  understanding  between
the parties, and supersedes  all  other agreements, express or implied, between
the  parties  concerning  PATENT  APPLICATIONS  and  IMPROVEMENTS,  PROPRIETARY
INFORMATION, TRADE SECRETS, TECHNICAL  and SCIENTIFIC information, KNOW-HOW and
registered TRADEMARKS.

      20.02       A  provision of this Agreement  may  be  altered  only  by  a
writing signed by both parties, except as provided in Sections 20.00 and 20.01,
above.

                                  ARTICLE XXI
                                    MARKING

      21.00       LICENSEE  shall  place  in a conspicuous location on LICENSED
PRODUCT, a patent notice, in accordance with  the  Statutes  of U.S. or Foreign
Patent  Law.  LICENSEE agrees to mark any LICENSED PRODUCT or LICENSED  PROCESS
and TECHNOLOGY used or covered by any PATENT(S), with the serial number of each
such patent.  With respect to PATENT APPLICATIONS and IMPROVEMENTS, PROPRIETARY
INFORMATION,  TRADE SECRETS, TECHNICAL and SCIENTIFIC information, KNOW-HOW and
registered TRADEMARKS,  LICENSEE  will respond to any request for disclosure in
accordance with the Statutes of Patent  Law  of  any  and  all  countries where
application has been made and/or the patent laws of any countries  affected  in
the  LICENSED  TERRITORY,  by  only  notifying  LICENSOR  of  the  request  for
disclosure.

                                 ARTICLE XXII
                                APPLICABLE LAW

      22.00       This  Agreement  shall  be constructed in accordance with the
substantive laws of the state of Nevada.

      1.1         The language under which this Agreement shall be interpreted,
            arbitrated or litigated shall be English.

                                 ARTICLE XXIII
                          NOTICES UNDER THE AGREEMENT

      23.00       For  the purpose of all written  communications  and  notices
between the parties, their addresses shall be:

            LICENSOR:         Paul Vose
                              513 N. Truesdale Rd.
                              Medical Lake, WA  99022
            Phone:            (509) 954-9056
            Fax:              (509) 428-6846
            Attention:        Dr. Paul V. Vose

            LICENSEE:         Integrated Micrometallurgical Systems, Inc.
                              7925 North Espe Rd.
                              Spokane, WA  99217
            Phone:            (509) 868-7701
            Fax:              (509) 467-4993
            Attention:        Larry K. Davis, Secretary

or any other addresses of  which  either  party shall notify the other party in
writing.

      IN WITNESS WHEREOF the parties have caused  this Agreement to be executed
by  their duly authorized officers and/or as an individual  on  the  respective
dates and at the respective places hereinafter set forth.

                                           LICENSEE

                                           INTEGRATED MICROMETALLURGICAL
                                           SYSTEMS, INC.

                                           By: /s/ Larry Davis
                                           --------------------------------
                                           Title: Larry K. Davis, Secretary
                                           Date: May 25, 2004

                                           LICENSOR

                                           PAUL V. VOSE

                                           By: /s/ Paul V. Vose
                                           --------------------
                                           Date: May 25, 2004

<PAGE>Exhibit 10.2

                                AGREEMENT

This Agreement is made and entered into as of this 10th day of February, 2005,
by and between American Defense International, Inc., a government relations,
consulting, and international business development firm having its principal
office at 1100 New York Avenue, NW, Suite 630, Washington, DC 2000S ("ADI") and
Integrated Micrometallurgical Systems, Inc., having its principal
office at P.O. Box 48441 Spokane, WA 99228-1441 ("IMS").

                           W I T N E S S E T H

WHEREAS, ADI wishes to provide government relations, consulting, and business
development services; to IMS and

WHEREAS, IMS wishes to obtain the services of ADI as set forth in accordance
with this agreements

NOW THEREFORE, in consideration of the foregoing recitals and the mutual
covenants, terms, conditions, and agreements hereafter provided, the parties
mutually agree as follows:

1. Effective Date.  This Agreement shall take effect on March 1, 2006 and shall
continue through February 28, 2008.  Following the expiration of the initial
term hereof, this Agreement shall automatically be renewed for successive one
(1) year terms, unless either party gives the other written notice of intent
not to renew at least thirty (30) days prior to the expiration of the then-
existing term.

2.  Services and Compensation.  ADI shall provide TIER II consulting and
business development services to IMS.  IMS and ADI shall agree as to the nature
and extent of the services to foe provided.  ADI will organize a "strategic
roadmap" meeting with ADI-IMS team.

As compensation for its services, IMS agrees to pay $30,000 annually, payable
in equal monthly installments of $2,500 per month for the services of ADI. Such
payment shall be due on the first day of each month beginning on February 1,
2006.

In addition, once ADI is successful in securing, either directly or indirectly,
government funding and/or sales for INS, IMS agrees to increase its monthly
retainer to a mutually agreed upon figure by IMS and ADI with a goal of
eventually moving to TIER I service and fee structure.

In addition, if ADI is successful in securing government or non-government
sales for IMS, IMS agrees to pay ADI 3%; of any resulting transaction.

The parties understand and agree that any and all compensation paid

                                                    Page 1 of 3
<PAGE>

to ADI will not be paid out of U.S. government appropriated funds.  All
fees and bonuses paid to ADI by IMS shall come out of IMS' profits and/or
general operating funds, and it is the intention of the parties to be in full
compliance with 31 USC sections l350 through 1352.

3.  Expenses.  IMS will reimburse ADI for all reasonable pre-approved expenses
made in the performance of its duties under this Agreement.  Routine
reimbursable disbursement will include messenger service, telephone calls,
transportation, meals, lodging, and travel.

4.  Indemnification.  IMS shall indemnify and hold ADI harmless from and
against any and all liability lose, damage, cost or expense (including
reasonable attorney's fees) resulting from the acts or omissions, negligence or
intentional wrongdoing of IMS. ADI shall indemnify and hold IMS harmless from
and against any and all liability, loco, damage, coat or expense (including
reasonable attorney's fees) resulting from the acts or omissions,, negligence
or intentional wrongdoing of ADI.

5.  Independent Contractor.  ADI will act as an independent contractor in the
performance of its duties under this Agreement, ADI is not responsible for the
acts of IMS or representations made by IMS upon which ADI acts in providing
services under this Agreement. The Parties are independent from each other, and
no Party shall have the right to enter into any obligation whatsoever on behalf
of the other Party, unless expressly authorized in advance.  Neither Party
shall be held responsible for the other Party's actions.

6.  Assignment.  This agreement way not be assigned by IMS or ADI without the
prior written consent of both parties'.

7.  Non-Disclosure.  ADI agrees to hold all IMS proprietary information and
intellectual property in trust and confidence.  ADI agrees not to publish,
disseminate, or disclose such information without the prior consent of IMS.

8.  Applicable Law.  This Agreement shall be construed, interpreted, and
governed by and in accordance with the laws of the District of Columbia without
regard to the principles of conflicts of laws.

9.  Notices.  Notices shall be sent to the parties at the addresses first set
forth above.  Any person to whom notice may be given hereunder may from time to
time change said address by written notice through the U.S. mail service or
equivalent service such as Federal Express.

10.  Severability.  If a court of competent jurisdiction declares that any term
or provision of this agreement is invalid or unenforceable then:  1) the
remaining terms and provisions shall be unimpaired, and 2) the invalid or
unenforceable term or provision shall be deemed replaced by a term or provision
that is valid and enforceable and that comes closest to expressing the
intention of the invalid or unenforceable terms or provisions.

                                                    Page 2 of 3
<PAGE>

11.  Entire Agreement.  This Agreement constitutes the entire agreement among
the parties with respect to the matters contained herein.  Any modification or
amendment to this Agreement must be made only by written mutual consent of both
parties.

IN WITSESS WHEREOF, the parties have executed this Agreement, the day, month,
and year first above written.

                      Integrated Micrometallurgical Systems, Inc.

                      By:  /s/ Werner Huss
                      --------------------
                               Werner Huss
                               President

                      American Defense International, Inc.

                      By:  /s/ Michael H. Herson
                      --------------------------
                               Michael H. Herson
                               President

                                                    Page 3 of 3
<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00106-of-00352.parquet"}]]